home.aspx

 
. home.aspx home.aspx

ARCHIVED NEWS


    CHRONIC PAIN: NEW COMPOUND MAY REPLACE OPIOIDS

    Jul 19, 2018

    Researchers tested an alternative to opioids in a mouse model of chronic pain and found it to be safe, effective, and possess none of the side effects of opioids. Man taking pills a new compound may soon replace opioids in the treatment of chronic pain. The National Institutes of Health (NIH) estima...


    READ MORE

    https://Pharmaceutical.report/news-article.aspx?ID=17801780

    RAPID INCREASE IN DEATHS DUE TO ALCOHOL-RELATED LIVER DISEASE

    Jul 19, 2018

    A new study identifies a worrying trend: deaths due to cirrhosis, or liver disease, as a result of alcohol consumption, are on the rise across the United States. Bottle and glass filled with beer deaths due to liver disease are on the rise in the U.S., and researchers warn that alcohol use is to bla...


    READ MORE

    https://Pharmaceutical.report/news-article.aspx?ID=17811781

    PFIZER MOVES HAEMOPHILIA GENE THERAPY INTO PHASE 3

    Jul 19, 2018

    US pharma giant Pfizer and partner Spark Therapeutics has begun a phase 3 trial of a gene therapy for patients with hemophilia B, which could see an end to patients needing constant injections to prevent bleeding. Pfizer’s announcement sets up a rivalry with Netherlands biotech uniQure, which ...


    READ MORE

    https://Pharmaceutical.report/news-article.aspx?ID=17821782

    NOVARTIS PAYS UP TO $1 BILLION FOR POTENTIAL ECZEMA DRUG

    Jul 19, 2018

    Swiss pharma Novartis is to pay up to $1 billion to Galapagos and MorphoSys for exclusive rights to a skin drug, which will further strengthen Novartis’s leadership position in the immunology field. Belgo-Dutch biotech Galapagos and Germany’s MorphoSys have signed a global license agreem...

    PIOTR WNUK
    READ MORE

    https://Pharmaceutical.report/news-article.aspx?ID=17831783

    AZ SUFFERS SETBACK AS NICE SLAPS RESTRICTIONS ON FASENRA

    Jul 19, 2018

    NICE has recommended in a draft decision that AstraZeneca’s latest lung drug Fasenra can be funded by the NHS in severe asthma – but only in patients that are ineligible for GlaxoSmithKline’s rival. AstraZeneca’s Fasenra (benralizumab) is one of a group of new drugs it hopes ...


    READ MORE

    https://Pharmaceutical.report/news-article.aspx?ID=17841784

    PHILANTHROPISTS DONATE $30M TOWARDS FINDING ALZHEIMER’S CURE

    Jul 18, 2018

    A coalition of philanthropists has announced they are donating more than $30 million in a drive to combat Alzheimer’s disease. Bill Gates and Leonard Lauder are among those who have joined forces to launch the Diagnostic Accelerator, a tool that develops biomarkers that could lead to the early...


    READ MORE

    https://Pharmaceutical.report/news-article.aspx?ID=17751775

    FDA APPROVES JANSSEN’S HIV COMBINATION SYMTUZA

    Jul 18, 2018

    Janssen has won US approval for its once-daily HIV pill Symtuza (D/C/F/TAF), which it hopes will improve patient adherence and resistance to treatment. Symtuza (D/C/F/TAF) combines Janssen’s darunavir with Gilead’s cobicistat, emtricitabine and tenofovir alafenamide in a single pill and ...


    READ MORE

    https://Pharmaceutical.report/news-article.aspx?ID=17761776

    WHAT HAPPENS TO DATA FROM AT-HOME ANCESTRY DNA KITS?

    Jul 18, 2018

    Home DNA kits are extremely popular now. Bringing DNA and genetic testing to the home market is a huge advance in science and technology, but what are the risks? Current testing methods allow a researcher with a DNA sample to find out information on ancestry, ethnic origin, medical history, dis...

    LABROOTS INC.
    READ MORE

    https://Pharmaceutical.report/news-article.aspx?ID=17771777

TRENDING NEWS


    3D-PRINTED PLACENTA-ON-A-CHIP MIMICS STRUCTURE OF PLACENTAL MEMBRANE

    Aug 17, 2018

    Researchers at TU Wien in Vienna have developed a placenta-on-a-chip microfluidic device which uses a femtosecond laser-based 3D-printing method to create a customized hydrogel membrane. The printed membrane is populated with placental cells and mimics the microstructure of the placental barrier. Th...

    TU WIEN
    READ MORE

    https://www.medgadget.com/2018/08/3d-printed-placenta-on-a-chip-mimics-structure-of-placental-membrane.html1871

    HIV DRUG CUTS VIRAL LOAD, BOOSTS IMMUNITY IN YALE STUDY

    Aug 17, 2018

    A Yale University study has found ibalizumab reduced viral replication and increased the count of immune cells in HIV patients, raising hopes for a new form of treatment for the disease. Approved therapies use a cocktail of nucleoside and nucleotide reverse transcriptase inhibitors to prevent viral ...


    READ MORE

    https://pharmaphorum.com/news/ibalizumab-cuts-hiv-viral-load/1872

    REGENERON/TEVA PAIN DRUG FASINUMAB ON TARGET IN PHASE 3

    Aug 17, 2018

    Regeneron and Teva have announced positive top-line phase 3 results from their fasinumab, as the companies chase Pfizer and Lilly in the race to market a new class of non-opioid painkillers. Fasinumab is from a class of drugs targeting nerve growth factor (NGF), which plays a central role in the reg...


    READ MORE

    https://pharmaphorum.com/news/regeneron-teva-pain-drug-fasinumab-target-phase-3/1875

    PFIZER INVESTS IN MRNA VACCINE POWERHOUSE BIONTECH

    Aug 16, 2018

    Pfizer is to pay German company BioNTech up to $425m for a multi-year collaboration in the development of more effective influenza vaccines, joining other pharma giants in a promising mRNA-based race. Under the terms of the agreement, BioNTech received a $120m upfront payment consisting of a mix of ...


    READ MORE

    https://pharmaphorum.com/news/pfizer-invests-mrna-vaccine-biontech/1873

    HACKERS COULD TAKE CONTROL OF MEDICAL DEVICES, MCAFEE WARNS

    Aug 16, 2018

    Research published by the cybersecurity company, McAfee, shows it is possible to modify real-time patient heart monitor data by hacking into a hospital network and gaining control of medical devices. The report published by McAfee proves that hackers could easily alter patients’ vital signs by...


    READ MORE

    https://pharmaphorum.com/news/mcafee-hacks-vital-medical-equipment/1874

    THIS DEVICE HELPS IMPROVE ACCURACY OF DIALYSIS CATHETER PLACEMENT

    Aug 15, 2018

    Patients on hemodialysis have to undergo vascular access procedures, typically arteriovenous fistulas or arteriovenous grafts. Some, though, are limited to tunneled cuffed catheters due to heart failure or poor cardiac reserve. Properly placing tunneled cuffed catheters can be challenging and failur...

    OKAYAMA UNIVERSITY
    READ MORE

    https://www.medgadget.com/2018/08/this-device-helps-improve-accuracy-of-dialysis-catheter-placement.html1866

    VIRTUAL REALITY AND NEURAL STIMULATION TO HELP AMPUTEES USE THEIR PROSTHESES

    Aug 14, 2018

    Researchers at the Ecole Polytechnique Fédérale de Lausanne in Switzerland have developed a new technique to help amputees use their prostheses. The method involves virtual reality and neural stimulation to help change an amputee’s “phantom limb” to more closely match...


    READ MORE

    https://www.medgadget.com/2018/08/virtual-reality-and-neural-stimulation-to-help-amputees-use-their-prostheses.html1867

    DROWNING IN DRUGS: INTERVIEW WITH CARNEGIE MELLON’S DIANE NELSON

    Aug 14, 2018

    One of the most engaging areas of research these days is improving drug delivery. Here at Medgadget, we often share news about technological advances in nanomedicine that promise improved delivery to tumor sites, or newly designed gadgets that increase drug delivering efficacy. Rarely do we hear abo...


    READ MORE

    https://www.medgadget.com/2018/08/drowning-in-drugs-an-interview-with-carnegie-mellons-diane-nelson.html1868

    ACTISOUND INTENSE THERAPEUTIC ULTRASOUND DEVICE CLEARED IN EUROPE

    Aug 14, 2018

    Guided Therapy Systems, based in Mesa, Arizona, landed EU CE mark approval (via Ardent Sound Inc., Guided’s partner, and manufacturer) for the Actisound Intense Therapeutic Ultrasound device. It’s intended to help recover from a variety of injuries and chronic pain resulting from interna...


    READ MORE

    https://www.medgadget.com/2018/08/actisound-intense-therapeutic-ultrasound-device-cleared-in-europe.html1869

    GN HEARING UNVEILS RESOUND LINX QUATTRO ADVANCED HEARING AID

    Aug 14, 2018

    GN Hearing, a company that makes audio technology that appears under names such as Beltone, Interton, and Jabra, just announced new hearing aid called ReSound LiNX Quattro. The firm describes it as “the world’s first Premium-Plus hearing aid,” delivering what it believes is the bes...

    GN HEARING
    READ MORE

    https://www.medgadget.com/2018/08/gn-hearing-unveils-resound-linx-quattro-advanced-hearing-aid.html1870

    STUDY REVEALS BROAD 'GENETIC ARCHITECTURES' OF TRAITS AND DISEASES

    Aug 13, 2018

    Scientists at Johns Hopkins Bloomberg School of Public Health have developed a powerful method for characterizing the broad patterns of genetic contributions to traits and diseases. The new method provides a "big picture" of genetic influences that should be particularly helpful in designi...

    UNIVERSITY BLOOMBERG
    READ MORE

    https://medicalxpress.com/news/2018-08-reveals-broad-genetic-architectures-traits.html1861

    3D PRINTED SILICONE AND STEM CELL IMPLANT TO TREAT SPINAL CORD INJURIES

    Aug 13, 2018

    Spinal cord injuries are notorious for the disabilities they cause and for the difficulty of finding a way to fix them. At the University of Minnesota, researchers are pointing to a potential solution in the form of 3D printed scaffolds seeded with neuronal stem cells. The team has already created a...

    UNIVERSITY OF MINNESOTA
    READ MORE

    https://www.medgadget.com/2018/08/3d-printed-silicone-and-stem-cell-implant-to-treat-spinal-cord-injuries.html1862

    ARTIFICIAL INTELLIGENCE OPTIMIZES CHEMO AND RADIOTHERAPY TO TREAT GLIOBLASTOMAS

    Aug 13, 2018

    Patients with glioblastoma, a persistent and difficult to treat brain cancer, often end up suffering through multiple rounds of chemo and radiation therapy. Scientists at MIT have been working on harnessing the power of artificial intelligence to better optimize the therapy dosages, sparing the pati...

    MIT
    READ MORE

    https://www.medgadget.com/2018/08/artificial-intelligence-optimizes-chemo-and-radiotherapy-to-treat-glioblastomas.html1863

    HOSPITAL INTRODUCING HOLOLENS AUGMENTED REALITY INTO THE OPERATING ROOM

    Aug 13, 2018

    Alder Hey, an important children’s hospital in Liverpool, England, is working on integrating Microsoft HoloLens augmented reality technology into its operating theaters. The HoloLens is a headset that is able to overlay digital images onto a person’s field of view, essentially mixing vir...

    ENGADGET
    READ MORE

    https://www.medgadget.com/2018/08/hospital-introducing-hololens-augmented-reality-into-the-operating-room.html1864

    HAILIE INHALER MONITORING SYSTEM NOW AVAILABLE DIRECT TO CONSUMERS

    Aug 13, 2018

    Adherium, a Silicon Valley firm, is releasing its Hailie system for inhaler monitoring in the United States. The company received FDA clearance to sell the product over the counter, allowing patients to work toward improved compliance with regards to their medications. The system includes a sensor t...

    ADHERIUM
    READ MORE

    https://www.medgadget.com/2018/08/hailie-inhaler-monitoring-system-now-available-direct-to-consumers.html1865

    FIRST PATIENT RECEIVES MEDTRONIC’S EXTRAVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

    Aug 10, 2018

    A pilot study is getting underway to evaluate a new Medtronic implantable cardioverter defibrillator that doesn’t require leads to be placed inside the heart or veins. The Extravascular Implantable Cardioverter Defibrillator (EV ICD) system can deliver defibrillation shocks as well as pacing s...

    MEDTRONIC
    READ MORE

    https://www.medgadget.com/2018/08/first-patient-receives-medtronics-extravascular-implantable-cardioverter-defibrillator-in-pilot-study.html1860

SPOTLIGHT

Dramatic changes in U.S. healthcare over the last few years have forced a rethinking of the partnerships pharmaceutical companies to form with groups representing patients and families. inVentiv Health Public Relations Group interviewed dozens of patient advocacy organizations to understand how they

RESOURCES

Events